Equities analysts predict that Envision Healthcare (NYSE:EVHC) will announce $0.64 earnings per share for the current quarter, Zacks reports. Eight analysts have issued estimates for Envision Healthcare’s earnings, with estimates ranging from $0.61 to $0.66. Envision Healthcare posted earnings of $0.77 per share in the same quarter last year, which suggests a negative year over year growth rate of 16.9%. The company is scheduled to issue its next quarterly earnings results on Tuesday, May 1st.
On average, analysts expect that Envision Healthcare will report full year earnings of $3.61 per share for the current year, with EPS estimates ranging from $3.55 to $3.66. For the next financial year, analysts anticipate that the business will post earnings of $4.07 per share, with EPS estimates ranging from $3.78 to $4.22. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side analysts that that provide coverage for Envision Healthcare.
Envision Healthcare (NYSE:EVHC) last announced its quarterly earnings data on Tuesday, February 27th. The company reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.45 by $0.14. Envision Healthcare had a negative net margin of 2.52% and a positive return on equity of 4.62%. The company had revenue of $2 billion during the quarter, compared to analysts’ expectations of $1.97 billion. During the same quarter in the prior year, the company posted $1.15 EPS. The business’s revenue was up 68.0% on a year-over-year basis.
A number of brokerages have recently issued reports on EVHC. ValuEngine cut shares of Envision Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, April 2nd. SunTrust Banks increased their price objective on shares of Envision Healthcare to $45.00 and gave the company a “buy” rating in a research note on Thursday, March 1st. Mizuho set a $38.00 price objective on shares of Envision Healthcare and gave the company a “hold” rating in a research note on Friday, March 2nd. Jefferies Group set a $46.00 price objective on shares of Envision Healthcare and gave the company a “buy” rating in a research note on Thursday, March 15th. Finally, Robert W. Baird restated an “outperform” rating and issued a $50.00 price objective (up previously from $45.00) on shares of Envision Healthcare in a research note on Wednesday, March 7th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $42.57.
Several institutional investors and hedge funds have recently bought and sold shares of the company. Green Square Capital LLC grew its holdings in shares of Envision Healthcare by 64.5% in the 4th quarter. Green Square Capital LLC now owns 30,553 shares of the company’s stock worth $1,056,000 after purchasing an additional 11,982 shares during the last quarter. Xact Kapitalforvaltning AB grew its holdings in shares of Envision Healthcare by 22.0% in the 4th quarter. Xact Kapitalforvaltning AB now owns 17,850 shares of the company’s stock worth $617,000 after purchasing an additional 3,223 shares during the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its holdings in shares of Envision Healthcare by 21.2% in the 4th quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 60,191 shares of the company’s stock worth $2,080,000 after purchasing an additional 10,512 shares during the last quarter. Sawtooth Solutions LLC grew its holdings in shares of Envision Healthcare by 47.8% in the 4th quarter. Sawtooth Solutions LLC now owns 12,525 shares of the company’s stock worth $433,000 after purchasing an additional 4,053 shares during the last quarter. Finally, OLD Mutual Customised Solutions Proprietary Ltd. grew its holdings in shares of Envision Healthcare by 88.2% in the 4th quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 6,401 shares of the company’s stock worth $221,000 after purchasing an additional 3,000 shares during the last quarter.
Shares of EVHC stock traded down $1.11 during mid-day trading on Tuesday, reaching $37.79. The company’s stock had a trading volume of 2,066,619 shares, compared to its average volume of 2,354,322. Envision Healthcare has a 1-year low of $23.77 and a 1-year high of $64.00. The stock has a market cap of $4,569.76, a price-to-earnings ratio of 15.24, a P/E/G ratio of 0.87 and a beta of 0.42. The company has a debt-to-equity ratio of 0.87, a quick ratio of 3.38 and a current ratio of 3.40.
TRADEMARK VIOLATION WARNING: “$0.64 Earnings Per Share Expected for Envision Healthcare (EVHC) This Quarter” was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another site, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/04/08/0-64-earnings-per-share-expected-for-envision-healthcare-evhc-this-quarter.html.
About Envision Healthcare
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.
Get a free copy of the Zacks research report on Envision Healthcare (EVHC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.